| Name | Title | Contact Details |
|---|
Innoviti started its payments business in 2008 and quickly established itself as a pioneer in using technology to solve real-world payment problems for merchants. Using its indigenously developed and patented payments platform, Innoviti has delivered i...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
insideBIGDATA is a news outlet that focuses on Big Data Analytics, AI, machine learning, and deep learning.
Since 1986, AEM has provided its customers with leading edge technological solutions to complex engineering and business challenges. Now AEM is pleased to offer the ability to place orders with us through our SeaPort Enhanced (SeaPort-e) contract
Intuity Solutions is a company that helps clients assess, design, build, run, manage and innovate their IT infrastructure and processes.